Byol Combi 2,5 mg/1,25 mg tvrde kapsule
| Name | Byol Combi 2,5 mg/1,25 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-785874468 |
| Active Substance | ramipril bisoprololfumarat |
| Composition | svaka tvrda kapsula sadrži 2,5 mg ramiprila i 1,25 mg bisoprololfumarata |
| Pharmaceutical Form | Kapsula, tvrda |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 11.05.2022 |
| MA Period of Validity | 11.05.2027 |
| Classification Number | UP/I-530-09/20-01/296 |
| Registration Number | 381-12-01/154-22-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BX05 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
